The book makes interesting reading. It is an account of the close link of marketing by the companies/manufactures and medical care, especially in the USA. Since 19 th century, there has been a medical business system. In the 20 th century, there was a lot of capital investment by wealthy investors in medical business who encouraged the selective growth of more profitable services and technologies.
The book emphasizes more on Radiology and Radiotherapy industry from the days of powerful new form of energy in 1890's to proton therapy with skyrocketing cost 1940's onwards. The author discussed the aura of scientific inventions of complex technologies over the medicine and at the same time need to have evidence-based medicine. She observes that in US billions of dollars were spent, those days yearly on medical over /under treatment.
Part I: In early 20 th century, A. Carnegies and business magnets funded institutions like Massachusetts and California Institutes with mission of linking technological inventions to industrial production.
Chapter 2 describes the Medical Radium Industry. Soon after Madam Curie and Pierre Curie discovered Radium in 1898, the industrialist, Emile Armet de Lisle built a refinery to provide more Radium and many surgeons started using it for treatment. Medical journals advertised the radiation treatments along with physician offering there. Processing Radium was a status symbol. The book describes with details how Radium industry was a flourishing industry in the US those days. It also described the politics involved in controlling Radium industry. From 1930's onward, the Radium use was reduced due to new X-ray tube in the market which was more effective.
Chapter 3 gives details of how General Electric company became the most dominant X-ray industry. General Electric company played a dynamic role in developing X-ray therapy soon after the discovery of X-ray by Roentgen in 1895. In 1913, William Coolidge an engineer with GE developed X-ray tube which was much better than existing. They later developed 200 KV therapy tube which revolutionized the X-ray business. They escalated to million volt tube in Chicago hospital. In 1934, GE announced a now resonance transformer which was used in New York Memorial hospital for supervoltage therapy.
Chapter 4 discusses the role of competing research universities. The California Institute of Technology (Caltech), University of California (UC), and Massachusetts Institute of Technology (MIT) led the way to build the high-voltage technology. They attracted donors by emphasizing medical as well as industrial use of their new machines and also offered the machine to physician for sending patients for treatment in their laboratories. The book describes the competitive research and development of these universities for megavoltage treatment.
The result of this had been the development of neutron treatment by Lawrence and megavoltage X-rays by Van de Graaff. Simultaneously, many medical literature started reviewing the results of radiation treatment also. The reports and claims began to appear in medical literature far too early to evaluate clinical effectiveness! It was felt then that the growth of the field owned more to professional, institutional, and industrial aspirations than did to improved cancer control.
Part II: It investigates the impact of wartime and postwar economics. There was a massive industrial growth for World War II. Military research contributed to medical technology as high-powered radiotherapy devices were made based on microwaves developed for radar. Furthermore, artificial radioactive elements were made in reactors for the atom bomb. Private companies augmented the growth. FORD Foundation hospital's Grants Program distributed $200 million to 3000 US firms manufacturing hospital equipment.
Health insurance also grew very rapidly and helped medical industry and hospitals. In 1950, there was 6 th International Congress of Radiology where companies showcased their products to radiologists and radiation physicists.
Chapter 5 outlines how academia and industrial engineers worked with radiologists to attract funding to build new devices and collaborated with established companies to manufacture them. Chapter 8 describes the politics in radiation therapy for the growth of the devices and test the clinical effectiveness. By 1970s, 5-year survival studies claimed that cure rates of cancer of cervix had rose from 25% to 75% due to megavoltage radiation. However, it was partly due to the increase of provincial cancer clinics and Pap smear use. The author gave some studies from California where surgery and radiation treatment for cancer of the cervix and breast are discussed. It was found that combined treatment may be beneficial.
Although there was no clear benefit of supervoltage machines, they were preferred due to sophisticated technology and higher productivity. Despite the lack of evidence, the growth of linear accelerator was phenomenal in the US. Total installations rose to 1000 by 1980s, 2000 by 1990s, and 3000 in early 2000s! Linear accelerators were new thing and conferred greater institutional prestige. The author further elaborated the policies which expanded radiation therapy facilities. In 1965, Regional Medical Programme (RMP) and Blue-ribbon policy which strengthened elite centers for specialty services through RMP-established networks. The hospitals were applying to buy linear accelerators as they will improve hospital market positions and not because they will cure more! Part III: This part describes the entrepreneurship and financial firms contributed to medical care during 1970s to 2010s. Chapter 9 described the advent of proton therapy. In 1980's, the investigators were reporting that photon has reached the peak of clinical performance and any further increase in energy will not help and other particles like neutron and proton therapies were being explored. Sweden's University of Upsala used proton for clinical purpose in 1957 and Massachusetts General Hospital in 1961. California's Loma Linda university announced the first hospital-based proton therapy center. Ion Beam Applications (IBA), Varian, and Hitachi were leading companies to enter the market for proton therapy. The author details about the growth of proton therapy, health policies, insurance challenges for proton therapy, and particle centers globally.
In chapter 10, the author discusses the professional standards, patterns of care studies, radiation treatment effectiveness, and various clinical trials. The author has raised the issue of Food and Drug Administration (FDA's) 510 (k) notification process. This process eliminates any testing or evaluation of equipment but just compares with earlier similar models and certifies it. The author claims that nearly half of FDA Advisory Committee members had ties with it in the form of stocks, research grants etc.! Finally, in chapter 11, the author discusses the key market strategies such as monopolizing populations, disease and technologies, design high-cost technologies, compete for patients and doctors using technology, and integrate medical care into finance through insurance and debt, etc., The author concludes that there is a need to build more effective and efficient health-care system by winning over market strategies and choose health over wealth.
Overall, the book gives detailed account of market forces in medical, especially radiotherapy development. Reader gets surprised to know that right from Roentgen days market was shaping the radiotherapy treatment methods. It also highlights the close collaboration of industries with universities in the US, which helped in producing new inventions quickly at the large scale for the benefit of people. Every country, especially India should emulate this.
